- cafead   Apr 22, 2024 at 11:42: AM
via The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals (VNDA.O) to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic drugmakers Teva (TEVA.TA) and Apotex.
article source
article source